Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

69 trials with published results (14%)

Research Maturity

327 completed trials (69% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

2.9%

14 terminated out of 476 trials

Success Rate

95.9%

+9.4% vs benchmark

Late-Stage Pipeline

29%

139 trials in Phase 3/4

Results Transparency

21%

69 of 327 completed with results

Key Signals

69 with results96% success14 terminated

Data Visualizations

Phase Distribution

382Total
Not Applicable (115)
Early P 1 (4)
P 1 (54)
P 2 (70)
P 3 (66)
P 4 (73)

Trial Status

Completed327
Unknown62
Recruiting24
Not Yet Recruiting20
Withdrawn16
Terminated14

Trial Success Rate

95.9%

Benchmark: 86.5%

Based on 327 completed trials

Clinical Trials (476)

Showing 20 of 20 trials
NCT07532837Not ApplicableActive Not RecruitingPrimary

The Effect of Oral Probiotics on Allergic Rhinitis Symptoms and the Quality of Life

NCT02636933Terminated

Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters

NCT07527260Not ApplicableNot Yet Recruiting

Effects of Adenoidectomy on Symptoms and IgE Levels in Children With AR

NCT06547372Not ApplicableRecruiting

Dietary Intervention on Atopy

NCT07419230Not ApplicableRecruitingPrimary

Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project

NCT07453615Not ApplicableRecruiting

Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children

NCT04648930CompletedPrimary

Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies

NCT06960382Phase 1RecruitingPrimary

Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma

NCT05709977Not ApplicableCompletedPrimary

Acupuncture for Nasal Congestion in Allergic Rhinitis

NCT07455968Not ApplicableActive Not RecruitingPrimary

Free Diving Breathing Training in Allergic Rhinitis

NCT07453771Not ApplicableNot Yet RecruitingPrimary

Safety and Efficacy of Small Extracellular Vesicles Nebulizer in Patients With Allergic Rhinitis Complicated With Asthma

NCT07435714Not ApplicableNot Yet RecruitingPrimary

Facilitating Surgical Choice in Patient With Chronic Hypertrophic Rhinitis Using a Patient Decision Aid

NCT07308288Not ApplicableCompleted

Immune Nutrition in Pediatric Respiratory Allergy

NCT07415278Phase 4Active Not RecruitingPrimary

INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION

NCT06603935Not ApplicableEnrolling By InvitationPrimary

Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)

NCT01471184Not ApplicableCompletedPrimary

The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo

NCT02131038CompletedPrimary

Application of Ectoine Nasal Spray in Comparison With Cromolyn Sodium Containing Nasal Spray in Patients With Allergic Rhinitis

NCT06828484Not ApplicableActive Not RecruitingPrimary

Allergenic Extract Standardized Cat Hair AP in an Allergic Rhinitis Model.

NCT06038279Phase 1Completed

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

NCT07345442Phase 1CompletedPrimary

Study on the Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects

Scroll to load more

Research Network

Activity Timeline